Senti Biosciences, Inc. (SNTI)
NASDAQ: SNTI · Real-Time Price · USD
2.120
+0.010 (0.46%)
Nov 21, 2024, 11:21 AM EST - Market open
Senti Biosciences Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 10 | 29 | 62 | 291 | - | - |
| Market Cap Growth | -43.65% | -52.46% | -78.72% | - | - | - |
| Enterprise Value | 34 | 27 | -21 | 274 | - | - |
| Last Close Price | 2.12 | 6.60 | 14.10 | 98.60 | - | - |
| PS Ratio | - | 11.48 | 14.43 | 105.23 | - | - |
| PB Ratio | 0.61 | 0.44 | 0.49 | 4.81 | - | - |
| P/TBV Ratio | 0.65 | 0.44 | 0.49 | - | - | - |
| EV/Sales Ratio | - | 10.40 | - | 99.22 | - | - |
| Debt / Equity Ratio | 2.17 | 0.56 | 0.29 | 0.38 | 0.45 | 0.82 |
| Asset Turnover | - | 0.02 | 0.03 | 0.04 | 0.01 | - |
| Quick Ratio | 1.29 | 4.24 | 5.56 | 3.97 | 6.35 | 4.16 |
| Current Ratio | 1.92 | 5.62 | 5.68 | 4.14 | 6.52 | 4.36 |
| Return on Equity (ROE) | -143.27% | -85.91% | -52.94% | -121.15% | -81.21% | - |
| Return on Assets (ROA) | -37.51% | -26.83% | -27.97% | -34.86% | -36.67% | - |
| Return on Capital (ROIC) | -41.57% | -29.95% | -31.36% | -39.47% | -39.69% | - |
| Earnings Yield | -730.33% | -241.70% | -94.13% | -19.04% | - | - |
| FCF Yield | -360.02% | -219.16% | -123.34% | -13.83% | - | - |
| Buyback Yield / Dilution | -2.86% | -69.94% | -796.58% | 78.99% | -2.03% | - |
| Total Shareholder Return | -2.86% | -69.94% | -796.58% | 78.99% | -2.03% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.